PUBLIC CONTRACT · 2021

Medicamentos do grupo 20 com CHNM

Contract value: €41,473.98
Signed on: 11 February 2021
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 7499216

PUBLISHED SUBJECT

41/74/2021 - Medicamentos do grupo 20 com CHNM

Parties involved

Contracting body: Centro Hospitalar Universitário do Algarve, E. P. E.
Awardee: LABESFAL-LAB. ALMIRO, SA.; BAXTER MEDICO - FARMACEUTICO, LDA
Place of performance: Portugal, Faro, Faro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: LABESFAL-LAB. ALMIRO, SA. · Tax ID 501169580
Awardee: BAXTER MEDICO - FARMACEUTICO, LDA · Tax ID 503347345

Values and timeline

Contract price: €41,473.98
Procedure base price: €45,957.00
Total effective price: Not reported on Portal BASE
Publication date: 24 February 2021
Award date: 11 February 2021
Signing date: 11 February 2021
Performance period: 360 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Preço ou custo
CPV code: 33690000-3 - Medicamentos vários
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
Framework agreement: CP 2020/3 - Corretivos da volémia e outras soluções estéreis
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5157149

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts